Status:
NOT_YET_RECRUITING
Effectiveness of Ketogenic Diet in MELAS Syndrome
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
MELAS Syndrome
Ketogenic Dieting
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of ketogenic diet in patients with MELAS syndrome. The main questions it aims to answer are: Clarify the curative effects of ketogenic...
Detailed Description
Ketogenic diet initiation and follow-up: 1. Before starting ketogenic diet treatment, patients with abnormal indexes such as liver, kidney, lipid, humoral immunity, hematuria, routine biochemical, el...
Eligibility Criteria
Inclusion
- Patients who meet the diagnostic criteria of MELAS and have received MELAS standard therapy but are not satisfied with the therapeutic effect, and voluntarily underwent ketogenic therapy
Exclusion
- Diseases with porphyria and disturbances in fatty acid transport and oxidation, severe electrolyte metabolism abnormalities, severe hemodynamic instability, acute respiratory infections, uncontrolled systemic infections, severe liver and renal failure, cholesterolemia (\>300mgdl), abnormal coagulation, acute pancreatitis, eating disorders, ketogenic diet intolerance, significant weight loss, poor compliance
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2038
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06013397
Start Date
September 1 2023
End Date
June 1 2038
Last Update
August 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310000